Andreea Waltmann1, Tyler R McKinnish2, Joseph A Duncan3. 1. Institute for Global Health and Infectious Disease, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina. 2. Department of Obstetrics and Gynecology, Washington University in St. Louis, St Louis, Missouri. 3. Division of Infectious Diseases, Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
Abstract
PURPOSE OF REVIEW: This review provides an update of nonviral, curable sexually transmitted infections (STIs) in pregnancy and summarizes our understanding of the current issues and controversies surrounding risk factors, screening, and treatment of STIs in pregnancy primarily in high-income countries (using the United States and the United Kingdom as examples). The infections covered in this review are syphilis, gonorrhea, chlamydia, trichomoniasis, and Mycoplasma genitalium infections. RECENT FINDINGS: Overall, limited modern data is available to update researchers and clinicians on the epidemiology and care of STIs in pregnancy. Though common risk factors can be identified among these STIs, like socioeconomic status and inadequate antenatal care, specific screening and treatment challenges vary by geography and pathogen. Wherever available, surveillance data and research evidence are often limited to nonpregnant patients, leading to imperfect pregnancy-specific risk estimates and obstetric lags in the development and adoption of new guidelines. We have identified three areas of opportunity that may enhance the effectiveness of current approaches and inform new ones: improved data collection and evidence-based screening practices; prompt and comprehensive therapy, including partner services, and evaluations of new treatment modalities; and equitable antenatal and sexual healthcare for all pregnant persons and their partners. SUMMARY: These findings highlight the need to revisit standards of screening and management of STIs in pregnancy in high-income countries.
PURPOSE OF REVIEW: This review provides an update of nonviral, curable sexually transmitted infections (STIs) in pregnancy and summarizes our understanding of the current issues and controversies surrounding risk factors, screening, and treatment of STIs in pregnancy primarily in high-income countries (using the United States and the United Kingdom as examples). The infections covered in this review are syphilis, gonorrhea, chlamydia, trichomoniasis, and Mycoplasma genitalium infections. RECENT FINDINGS: Overall, limited modern data is available to update researchers and clinicians on the epidemiology and care of STIs in pregnancy. Though common risk factors can be identified among these STIs, like socioeconomic status and inadequate antenatal care, specific screening and treatment challenges vary by geography and pathogen. Wherever available, surveillance data and research evidence are often limited to nonpregnant patients, leading to imperfect pregnancy-specific risk estimates and obstetric lags in the development and adoption of new guidelines. We have identified three areas of opportunity that may enhance the effectiveness of current approaches and inform new ones: improved data collection and evidence-based screening practices; prompt and comprehensive therapy, including partner services, and evaluations of new treatment modalities; and equitable antenatal and sexual healthcare for all pregnant persons and their partners. SUMMARY: These findings highlight the need to revisit standards of screening and management of STIs in pregnancy in high-income countries.
Authors: Jane Hitti; Pedro Garcia; Patricia Totten; Kathleen Paul; Sabina Astete; King K Holmes Journal: Sex Transm Dis Date: 2010-02 Impact factor: 2.830
Authors: Weiming Tang; Jessica Mao; Katherine T Li; Jennifer S Walker; Roger Chou; Rong Fu; Weiying Chen; Toni Darville; Jeffrey Klausner; Joseph D Tucker Journal: Sex Transm Infect Date: 2019-12-13 Impact factor: 3.519
Authors: Vanessa L Short; Patricia A Totten; Roberta B Ness; Sabina G Astete; Sheryl F Kelsey; Catherine L Haggerty Journal: Clin Infect Dis Date: 2009-01-01 Impact factor: 9.079
Authors: M Laga; F A Plummer; H Nzanze; W Namaara; R C Brunham; J O Ndinya-Achola; G Maitha; A R Ronald; L J D'Costa; V B Bhullar Journal: Lancet Date: 1986-11-15 Impact factor: 79.321
Authors: Kristina Adachi; Jiahong Xu; Nava Yeganeh; Margaret Camarca; Mariza G Morgado; D Heather Watts; Lynne M Mofenson; Valdilea G Veloso; Jose Henrique Pilotto; Esau Joao; Glenda Gray; Gerhard Theron; Breno Santos; Rosana Fonseca; Regis Kreitchmann; Jorge Pinto; Marisa M Mussi-Pinhata; Mariana Ceriotto; Daisy Maria Machado; Yvonne J Bryson; Beatriz Grinsztejn; Jack Moye; Jeffrey D Klausner; Claire C Bristow; Ruth Dickover; Mark Mirochnick; Karin Nielsen-Saines Journal: PLoS One Date: 2018-01-05 Impact factor: 3.240
Authors: Andreea Waltmann; Joseph A Duncan; Gerald B Pier; Colette Cywes-Bentley; Myron S Cohen; Marcia M Hobbs Journal: Curr Top Microbiol Immunol Date: 2022-03-05 Impact factor: 4.737
Authors: Akaninyene Noah; Ashley V Hill; Maria J Perez-Patron; Abbey B Berenson; Camilla R Comeaux; Brandie D Taylor Journal: Reprod Sci Date: 2022-02-25 Impact factor: 3.060